Intriguingly, some reports indicate a tumor-suppressive effect of HDAC1 and HDAC2, especially in T cells, where dosage-dependent deletion of the two HDAC enzymes resulted in induction of lymphomas [18,19]. The gene discussed is HDAC9; the disease is neoplasm.